The earnings conference call for the second quarter (Q2) and first half (H1) of FY27 is scheduled for Monday, 16th November, 2026 at 12:00 p.m.
Conference Call Dial-In Information:
- Registration Link: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=8392593&linkSecurityString=4b4ca72b77
- Dial-In Numbers: +91 22 6280 1239 and +91 22 7115 8140
- Participants are advised to dial in 10 minutes prior to the scheduled conference time.
Speakers from the company's management will be presenting. The document includes a standard disclaimer stating that forward-looking statements made during the call are subject to certain risks and uncertainties, such as significant changes in the economic environment in India and abroad, and that actual results may differ substantially from those expressed or implied. The company and its management disclaim responsibility for any action taken based on such statements and discussions.
The intimation letter is signed by Fredun Nariman Medhora, Managing Director (DIN: 01745348), on behalf of Fredun Pharmaceuticals Limited.